The Checkup by Singlecare
DECEMBER 6, 2024
Clonidine is a generic medication that treats hypertension (high blood pressure). Because clonidine works differently than other blood pressure medications, it also has several off-label uses including anxiety, insomnia, attention deficit hyperactivity disorder (ADHD), and alcohol withdrawal. Clonidine, also sold under the brand name Catapres, is available as a tablet and once-a-week skin patch.
Compounding Pharmacy of America
DECEMBER 6, 2024
Erectile dysfunction (ED) is often misunderstood as simply a sexual health concern, but it can signify much more. While many men experience occasional difficulties with sexual performance, persistent ED can be an early warning sign of serious underlying health issues such as cardiovascular disease, diabetes, or hormonal imbalances. Addressing ED is not just about improving […] The post Dont Ignore Erectile Dysfunction appeared first on Compounding Pharmacy of America.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 6, 2024
The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $16.5 billion for Catalent, a leading contract drug manufacturer. By taking this step, the executive arm of the European Union removed a significant obstacle to a deal that has generated debate over the extent to which competition in the pharmaceutical industry may be hindered.
Drug Topics
DECEMBER 6, 2024
Outside forces are at play, but pharmacists must turn inward to address some challenges in their profession.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
DECEMBER 6, 2024
Donald Moore discusses some of the obstacles that bispecific antibodies have faced in community cancer centers, including misconceptions coupled with a prevalent toxicity profile.
Drug Topics
DECEMBER 6, 2024
Nearly a year after the change to direct and indirect remuneration fees, pharmacy owners talk about how the ruling has impacted their lives.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
DECEMBER 6, 2024
Researchers assessed the importance of a nutritious diet and the role pharmacists play in providing dietary management services.
Pharmacy Times
DECEMBER 6, 2024
The US Department of Agricultures (USDA) guidance will help expedite H5N1 bird flu surveillance within the nations milk supply and dairy herds.
Drug Topics
DECEMBER 6, 2024
Catch up on important FDA news from the week of December 2.
Pharmacy Times
DECEMBER 6, 2024
Pharmacists can educate and encourage screenings for colon cancer to ensure it is discovered as early as possible.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
DECEMBER 6, 2024
Researchers observed data from 2010 to 2021 to better understand recent trends in US pharmacy closures and the specific pharmacy types that have been impacted.
Pharmaceutical Commerce
DECEMBER 6, 2024
Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.
Drug Topics
DECEMBER 6, 2024
Madison Irwin, PharmD, BCPS, discusses her career pharmacy and how she thinks high rates of chronic pain will impact the field in the coming years.
Pharmacy Times
DECEMBER 6, 2024
Durvalumab could offer further treatment for individuals with muscle-invasive bladder cancer.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
DECEMBER 6, 2024
Eli has announced a $3bn investment to expand its newly acquired manufacturing facility in Kenosha County, Wisconsin, in the US.
Pharmacy Times
DECEMBER 6, 2024
As experts in medication management and health education, pharmacists can work with the administration to promote effective strategies that reduce misinformation and improve public health outcomes.
Pharmaceutical Technology
DECEMBER 6, 2024
The new FDA guidance outlines how surrogate or intermediate clinical endpoints can support accelerated approval.
Pharmacy Times
DECEMBER 6, 2024
Jose Tinajero discusses how certain mutations can be indicators of blinatumomab treatment failure in patients with B-cell acute lymphoblastic leukemia.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
DECEMBER 6, 2024
A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.
Pharmacy Times
DECEMBER 6, 2024
The addition of samidorphan can support the antipsychotic efficacy of olanzapine while mitigating associated weight gain.
Pharmaceutical Technology
DECEMBER 6, 2024
Investment for companies developing cell and gene therapies (CGTs) was discussed during the GenScript Biotech Global Forum London 2024 conference held on 20 November 2024.
Pharmacy Times
DECEMBER 6, 2024
Children born moderate to late preterm also showed more behavior difficulties compared with those born early term or later.
Pharmaceutical Technology
DECEMBER 6, 2024
Centenarians present a unique opportunity for researchers to explore longevity, they demonstrate impressive resilience to illness and injury.
Pharmacy Times
DECEMBER 6, 2024
Pharmacists must make time for self-care and ensure a proper balance of work and life among their staff and themselves, according to National Association of Boards of Pharmacy Executive Director Al Carter.
Pharmaceutical Technology
DECEMBER 6, 2024
The US FDA has granted RMAT designation to Affimed and Artiva Biotherapeutics combination therapy for lymphoma.
Pharmacy Times
DECEMBER 6, 2024
The authors found high exposure to butylparaben and low exposure to 4-nonylphenol during pregnancy were risk factors for asthma development in children at 4 years of age.
Pharmaceutical Technology
DECEMBER 6, 2024
Muna has entered a research alliance with GSK to expedite Alzheimer's disease treatments by discovering and validating new drug targets.
Pharmacy Times
DECEMBER 6, 2024
Mazyar Shadman, MD, MPH, discusses the continued efficacy of zanubrutinib in patients with chronic lymphocytic leukemia.
Pharmaceutical Technology
DECEMBER 6, 2024
A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.
Pharmaceutical Commerce
DECEMBER 6, 2024
A guide to overcoming the top obstacles facing patient services programs today.
PharmExec
DECEMBER 6, 2024
Ziiheras addition as a category 2A treatment follows the FDAs accelerated approval of the drug for adults with previously treated, unresectable, or metastatic HER2-positive biliary tract cancer.
Pharmaceutical Commerce
DECEMBER 6, 2024
The companies will be financially committing $1 and $3 billion into their respective manufacturing facilities.
PharmExec
DECEMBER 6, 2024
Mohamed Haitham Ayad, CEO, co-founder, SPIMA Therapeutics, discusses the companys launch and how multiple institutions have supported its pipeline.
Expert insights. Personalized for you.
Let's personalize your content